One-time infusion of Hemgenix offers long-term durability, phase 3 HOPE-B trial shows
Global biotechnology company CSL Behring announced on Friday the four-year results from the pivotal HOPE-B study confirming the long-term durability…
Pharmaceuticals, Biotechnology and Life Sciences
Global biotechnology company CSL Behring announced on Friday the four-year results from the pivotal HOPE-B study confirming the long-term durability…
Ananda Pharma (AQSE: ANA), is a UK-based developer of licenced, CBD-based medicinal products, has appointed Andy Rust as a commercial adviser, to provide the company with expert advice on its drug development and commercialisation plans.
hVIVO has signed a contract with Inhalon Biopharma to assess its inhaled IN-002 antiviral candidate (“IN-002”) using the hVIVO Respiratory Syncytial Virus (RSV) Human Challenge Model.
Roche announced Monday that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY® anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody* to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who may be eligible for treatment with ENHERTU®.
Affluent Medical, a French medtech company at the forefront of developing advanced implantable devices, has reached a key milestone in its mission to improve men’s healthas by successfully completing the pilot phase of its clinical study for the Artus system, an innovative artificial urinary sphincter (AUS) designed to treat stress urinary incontinence in men.
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global…
Novadip Biosciences, a clinical stage biotechnology company specializing in regenerative medicine, Tuesday said it has completed the 12-month post-surgical visit…
AB2 Bio Ltd., a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven…
Moderna has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway…
Medix Biochemica, a global leader in the supply of critical raw materials for the in vitro diagnostics (IVD) industry, announced the acquisition of CANDOR Bioscience GmbH, a Germany-based developer and manufacturer of premium immunoassay solutions.